Share of branded drug costs in Medicare Part D gap in the U.S. 2016-2020

This statistic displays the projected distribution of cost-sharing for brand name drugs in the Medicare Part D coverage gap in the United States from 2016 to 2020. In 2016, five percent of the cost of brand name drugs is expected to be paid by CMS. Provisions of the Affordable Care Act mandate the gradual closure of the Medicare Part D coverage gap through pharmaceutical manufacturer discounts and CMS subsidies.

Cost sharing for branded drugs in the Medicare Part D coverage gap from 2016 to 2020

Paid by enrolleePaid by CMSManufacturer discount
201645%5%50%
201740%10%50%
201835%15%50%
201930%20%50%
202025%25%50%
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

December 2016

Region

United States

Survey time period

2016

Supplementary notes

All figures are forecasts.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Medicare"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.